Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB
NCT ID: NCT06616103
Last Updated: 2024-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
111 participants
OBSERVATIONAL
2024-09-26
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
NCT04722120
Quantitative US for Hepatic Steatosis
NCT04180631
Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction
NCT04027556
Prediction of Significant Liver Fibrosis
NCT06509230
Deep Learning Image Reconstruction for Abdominal CT of Hepatocellular Carcinoma Compared With 3-TESLA MRI
NCT06037343
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
computerized tomography
noncontrast abdominal CT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no chronic liver disease other than chronic hepatitis B
* Body mass index \>= 23
Exclusion Criteria
* unable to perform MRI examinations due to claustrophobia or metallic foreign body
* suspicious hepatic malignancy on previous imaging studies
* history of local treatment for hepatic lesions
* history of surgery or catheter insertion of liver or spleen
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeongin Yoo
Clinical assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RS-2023-00253896
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CHB prospective MEDIP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.